Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MINERALYS THERAPEUTICS, INC. (MLYS)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(10% Negative) MINERALYS THERAPEUTICS, INC. (MLYS) Reports Q2 2026 Financial Results

Comment Full text

TARSUS PHARMACEUTICALS, INC. (TARS)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(10% Negative) TARSUS PHARMACEUTICALS, INC. (TARS) Reports Q2 2026 Financial Results

Comment Full text

EVERTEC, INC. (EVTC)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) EVERTEC, INC. (EVTC) Reports Q2 2026 Financial Results

Comment Full text

BRILLIANT EARTH GROUP, INC. (BRLT)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) BRILLIANT EARTH GROUP, INC. (BRLT) Reports Q2 2026 Financial Results

Comment Full text

CASTLE BIOSCIENCES INC (CSTL)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) CASTLE BIOSCIENCES INC (CSTL) Reports Q2 2026 Financial Results

Comment Full text

BARRETT BUSINESS SERVICES INC (BBSI)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) BARRETT BUSINESS SERVICES INC (BBSI) Reports Q2 2026 Financial Results

Comment Full text

PENNANT GROUP, INC. (PNTG)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) PENNANT GROUP, INC. (PNTG) Reports Q2 2026 Financial Results

Comment Full text

BRAEMAR HOTELS & RESORTS INC. (BHR)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(30% Negative) BRAEMAR HOTELS & RESORTS INC. (BHR) Reports Q2 2026 Financial Results

Comment Full text

HOTH THERAPEUTICS, INC. (HOTH)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

(99% Neutral) HOTH THERAPEUTICS, INC. (HOTH) Announces Business Combination

Comment Full text

CREDIT ACCEPTANCE CORP (CACC)

  • SEC News
  • May 06, 2026, 20:07 UTC
  • 2
  • 1 comments

📋 Martin Jay D (Officer) plans to sell 1K shares of CREDIT ACCEPTANCE CORP (at $551.25 each, total $793K) Filed: May 06, 2026 | ID: 003346

Comment Full text
  • Previous
  • 1431
  • 1432
  • 1433
  • 1434
  • 1435
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(283143)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161741)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin